nodes	percent_of_prediction	percent_of_DWPC	metapath
Ganciclovir—SLC22A7—Glyburide—type 2 diabetes mellitus	0.144	0.228	CbGbCtD
Ganciclovir—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.12	0.189	CbGbCtD
Ganciclovir—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.107	0.169	CbGbCtD
Ganciclovir—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0909	0.143	CbGbCtD
Ganciclovir—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0614	0.0969	CbGbCtD
Ganciclovir—SLC22A6—Losartan—type 2 diabetes mellitus	0.0562	0.0886	CbGbCtD
Ganciclovir—SLC22A1—Metformin—type 2 diabetes mellitus	0.0541	0.0853	CbGbCtD
Ganciclovir—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000126	0.000371	CcSEcCtD
Ganciclovir—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000126	0.00037	CcSEcCtD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000126	0.00485	CbGpPWpGaD
Ganciclovir—Infection—Metformin—type 2 diabetes mellitus	0.000125	0.000369	CcSEcCtD
Ganciclovir—Insomnia—Valsartan—type 2 diabetes mellitus	0.000125	0.000369	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000125	0.000367	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000125	0.00481	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000125	0.00481	CbGpPWpGaD
Ganciclovir—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000125	0.000366	CcSEcCtD
Ganciclovir—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000124	0.000366	CcSEcCtD
Ganciclovir—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000124	0.000365	CcSEcCtD
Ganciclovir—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000124	0.000365	CcSEcCtD
Ganciclovir—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000124	0.000365	CcSEcCtD
Ganciclovir—Insomnia—Orlistat—type 2 diabetes mellitus	0.000124	0.000364	CcSEcCtD
Ganciclovir—Malaise—Losartan—type 2 diabetes mellitus	0.000124	0.000364	CcSEcCtD
Ganciclovir—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000124	0.000364	CcSEcCtD
Ganciclovir—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000124	0.000364	CcSEcCtD
Ganciclovir—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000124	0.000363	CcSEcCtD
Ganciclovir—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000124	0.000363	CcSEcCtD
Ganciclovir—Vertigo—Losartan—type 2 diabetes mellitus	0.000123	0.000363	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000123	0.000363	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000123	0.000363	CcSEcCtD
Ganciclovir—Somnolence—Valsartan—type 2 diabetes mellitus	0.000123	0.000362	CcSEcCtD
Ganciclovir—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000123	0.000362	CcSEcCtD
Ganciclovir—Leukopenia—Losartan—type 2 diabetes mellitus	0.000123	0.000362	CcSEcCtD
Ganciclovir—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000123	0.000361	CcSEcCtD
Ganciclovir—Skin disorder—Metformin—type 2 diabetes mellitus	0.000123	0.000361	CcSEcCtD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000123	0.00473	CbGpPWpGaD
Ganciclovir—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000122	0.000359	CcSEcCtD
Ganciclovir—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000122	0.000359	CcSEcCtD
Ganciclovir—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000122	0.000359	CcSEcCtD
Ganciclovir—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000122	0.000357	CcSEcCtD
Ganciclovir—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000122	0.000357	CcSEcCtD
Ganciclovir—Nausea—Glimepiride—type 2 diabetes mellitus	0.000121	0.000356	CcSEcCtD
Ganciclovir—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000121	0.000355	CcSEcCtD
Ganciclovir—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000121	0.000355	CcSEcCtD
Ganciclovir—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000121	0.000355	CcSEcCtD
Ganciclovir—Asthenia—Glyburide—type 2 diabetes mellitus	0.000121	0.000355	CcSEcCtD
Ganciclovir—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000121	0.000354	CcSEcCtD
Ganciclovir—Anorexia—Metformin—type 2 diabetes mellitus	0.00012	0.000354	CcSEcCtD
Ganciclovir—Cough—Losartan—type 2 diabetes mellitus	0.00012	0.000352	CcSEcCtD
Ganciclovir—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00012	0.000352	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.00012	0.000352	CcSEcCtD
Ganciclovir—Alopecia—Ramipril—type 2 diabetes mellitus	0.00012	0.000352	CcSEcCtD
Ganciclovir—Fatigue—Valsartan—type 2 diabetes mellitus	0.00012	0.000351	CcSEcCtD
Ganciclovir—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000119	0.000351	CcSEcCtD
Ganciclovir—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000119	0.000351	CcSEcCtD
Ganciclovir—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000119	0.00035	CcSEcCtD
Ganciclovir—Oedema—Irbesartan—type 2 diabetes mellitus	0.000119	0.00035	CcSEcCtD
Ganciclovir—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000119	0.00035	CcSEcCtD
Ganciclovir—Pruritus—Glyburide—type 2 diabetes mellitus	0.000119	0.00035	CcSEcCtD
Ganciclovir—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000119	0.000349	CcSEcCtD
Ganciclovir—Constipation—Valsartan—type 2 diabetes mellitus	0.000119	0.000349	CcSEcCtD
Ganciclovir—Infection—Irbesartan—type 2 diabetes mellitus	0.000118	0.000348	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000118	0.000348	CcSEcCtD
Ganciclovir—Fatigue—Orlistat—type 2 diabetes mellitus	0.000118	0.000347	CcSEcCtD
Ganciclovir—Hypotension—Metformin—type 2 diabetes mellitus	0.000118	0.000347	CcSEcCtD
Ganciclovir—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000118	0.000346	CcSEcCtD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—GAD2—type 2 diabetes mellitus	0.000118	0.00454	CbGpPWpGaD
Ganciclovir—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	0.000117	0.00452	CbGpPWpGaD
Ganciclovir—Pain—Orlistat—type 2 diabetes mellitus	0.000117	0.000344	CcSEcCtD
Ganciclovir—Myalgia—Losartan—type 2 diabetes mellitus	0.000117	0.000344	CcSEcCtD
Ganciclovir—Arthralgia—Losartan—type 2 diabetes mellitus	0.000117	0.000344	CcSEcCtD
Ganciclovir—Chest pain—Losartan—type 2 diabetes mellitus	0.000117	0.000344	CcSEcCtD
Ganciclovir—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000117	0.000344	CcSEcCtD
Ganciclovir—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000117	0.000343	CcSEcCtD
Ganciclovir—Anxiety—Losartan—type 2 diabetes mellitus	0.000117	0.000343	CcSEcCtD
Ganciclovir—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000116	0.000342	CcSEcCtD
Ganciclovir—Rash—Bromocriptine—type 2 diabetes mellitus	0.000116	0.000341	CcSEcCtD
Ganciclovir—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000116	0.00034	CcSEcCtD
Ganciclovir—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000116	0.00034	CcSEcCtD
Ganciclovir—Tension—Ramipril—type 2 diabetes mellitus	0.000116	0.00034	CcSEcCtD
Ganciclovir—Discomfort—Losartan—type 2 diabetes mellitus	0.000116	0.00034	CcSEcCtD
Ganciclovir—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000115	0.000339	CcSEcCtD
Ganciclovir—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000115	0.000339	CcSEcCtD
Ganciclovir—Headache—Bromocriptine—type 2 diabetes mellitus	0.000115	0.000339	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000115	0.000338	CcSEcCtD
Ganciclovir—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000115	0.000338	CcSEcCtD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000115	0.00443	CbGpPWpGaD
Ganciclovir—Nervousness—Ramipril—type 2 diabetes mellitus	0.000114	0.000336	CcSEcCtD
Ganciclovir—Dry mouth—Losartan—type 2 diabetes mellitus	0.000114	0.000336	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000114	0.0044	CbGpPWpGaD
Ganciclovir—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000114	0.000334	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000113	0.000333	CcSEcCtD
Ganciclovir—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000113	0.000333	CcSEcCtD
Ganciclovir—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000113	0.000333	CcSEcCtD
Ganciclovir—Confusional state—Losartan—type 2 diabetes mellitus	0.000113	0.000332	CcSEcCtD
Ganciclovir—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000113	0.000332	CcSEcCtD
Ganciclovir—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000113	0.000331	CcSEcCtD
Ganciclovir—Somnolence—Metformin—type 2 diabetes mellitus	0.000112	0.00033	CcSEcCtD
Ganciclovir—Oedema—Losartan—type 2 diabetes mellitus	0.000112	0.00033	CcSEcCtD
Ganciclovir—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000112	0.00033	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000112	0.000329	CcSEcCtD
Ganciclovir—Infection—Losartan—type 2 diabetes mellitus	0.000111	0.000328	CcSEcCtD
Ganciclovir—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000111	0.000327	CcSEcCtD
Ganciclovir—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000111	0.000327	CcSEcCtD
Ganciclovir—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000111	0.000327	CcSEcCtD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000111	0.00428	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000111	0.00427	CbGpPWpGaD
Ganciclovir—Tremor—Ramipril—type 2 diabetes mellitus	0.00011	0.000325	CcSEcCtD
Ganciclovir—Urticaria—Valsartan—type 2 diabetes mellitus	0.00011	0.000324	CcSEcCtD
Ganciclovir—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.00011	0.000323	CcSEcCtD
Ganciclovir—Decreased appetite—Metformin—type 2 diabetes mellitus	0.00011	0.000323	CcSEcCtD
Ganciclovir—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00011	0.000322	CcSEcCtD
Ganciclovir—Tachycardia—Losartan—type 2 diabetes mellitus	0.000109	0.000322	CcSEcCtD
Ganciclovir—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000109	0.000321	CcSEcCtD
Ganciclovir—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000109	0.000321	CcSEcCtD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000109	0.00421	CbGpPWpGaD
Ganciclovir—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000109	0.00032	CcSEcCtD
Ganciclovir—Fatigue—Metformin—type 2 diabetes mellitus	0.000109	0.00032	CcSEcCtD
Ganciclovir—Urticaria—Orlistat—type 2 diabetes mellitus	0.000109	0.00032	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000109	0.000319	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000109	0.00419	CbGpPWpGaD
Ganciclovir—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000108	0.000319	CcSEcCtD
Ganciclovir—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000108	0.000318	CcSEcCtD
Ganciclovir—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000108	0.000318	CcSEcCtD
Ganciclovir—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000108	0.000318	CcSEcCtD
Ganciclovir—Agitation—Ramipril—type 2 diabetes mellitus	0.000108	0.000318	CcSEcCtD
Ganciclovir—Constipation—Metformin—type 2 diabetes mellitus	0.000108	0.000317	CcSEcCtD
Ganciclovir—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000107	0.000315	CcSEcCtD
Ganciclovir—Anorexia—Losartan—type 2 diabetes mellitus	0.000107	0.000314	CcSEcCtD
Ganciclovir—Vomiting—Glyburide—type 2 diabetes mellitus	0.000107	0.000314	CcSEcCtD
Ganciclovir—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000107	0.000314	CcSEcCtD
Ganciclovir—Malaise—Ramipril—type 2 diabetes mellitus	0.000106	0.000312	CcSEcCtD
Ganciclovir—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000106	0.000312	CcSEcCtD
Ganciclovir—Rash—Glyburide—type 2 diabetes mellitus	0.000106	0.000312	CcSEcCtD
Ganciclovir—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000106	0.000311	CcSEcCtD
Ganciclovir—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000106	0.000311	CcSEcCtD
Ganciclovir—Vertigo—Ramipril—type 2 diabetes mellitus	0.000106	0.000311	CcSEcCtD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000106	0.00407	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000105	0.00407	CbGpPWpGaD
Ganciclovir—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000105	0.00031	CcSEcCtD
Ganciclovir—Headache—Glyburide—type 2 diabetes mellitus	0.000105	0.00031	CcSEcCtD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000105	0.00405	CbGpPWpGaD
Ganciclovir—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000105	0.000308	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000105	0.00404	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000105	0.00404	CbGpPWpGaD
Ganciclovir—Hypotension—Losartan—type 2 diabetes mellitus	0.000105	0.000308	CcSEcCtD
Ganciclovir—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000104	0.000306	CcSEcCtD
Ganciclovir—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000104	0.000305	CcSEcCtD
Ganciclovir—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000103	0.000304	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000103	0.000304	CcSEcCtD
Ganciclovir—SLC22A1—Neuronal System—ABCC8—type 2 diabetes mellitus	0.000103	0.00398	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000103	0.00398	CbGpPWpGaD
Ganciclovir—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000103	0.000302	CcSEcCtD
Ganciclovir—Cough—Ramipril—type 2 diabetes mellitus	0.000103	0.000302	CcSEcCtD
Ganciclovir—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000103	0.000302	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000102	0.0003	CcSEcCtD
Ganciclovir—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000102	0.0003	CcSEcCtD
Ganciclovir—Convulsion—Ramipril—type 2 diabetes mellitus	0.000102	0.0003	CcSEcCtD
Ganciclovir—Constipation—Irbesartan—type 2 diabetes mellitus	0.000102	0.0003	CcSEcCtD
Ganciclovir—Pain—Irbesartan—type 2 diabetes mellitus	0.000102	0.0003	CcSEcCtD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.000102	0.00393	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000102	0.00392	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000102	0.00392	CbGpPWpGaD
Ganciclovir—Insomnia—Losartan—type 2 diabetes mellitus	0.000101	0.000298	CcSEcCtD
Ganciclovir—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000101	0.000297	CcSEcCtD
Ganciclovir—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000101	0.000296	CcSEcCtD
Ganciclovir—Urticaria—Metformin—type 2 diabetes mellitus	0.0001	0.000295	CcSEcCtD
Ganciclovir—Chest pain—Ramipril—type 2 diabetes mellitus	0.0001	0.000295	CcSEcCtD
Ganciclovir—Arthralgia—Ramipril—type 2 diabetes mellitus	0.0001	0.000295	CcSEcCtD
Ganciclovir—Myalgia—Ramipril—type 2 diabetes mellitus	0.0001	0.000295	CcSEcCtD
Ganciclovir—Dyspnoea—Losartan—type 2 diabetes mellitus	0.0001	0.000294	CcSEcCtD
Ganciclovir—Anxiety—Ramipril—type 2 diabetes mellitus	0.0001	0.000294	CcSEcCtD
Ganciclovir—Nausea—Glyburide—type 2 diabetes mellitus	9.98e-05	0.000293	CcSEcCtD
Ganciclovir—Abdominal pain—Metformin—type 2 diabetes mellitus	9.98e-05	0.000293	CcSEcCtD
Ganciclovir—Dizziness—Gliclazide—type 2 diabetes mellitus	9.98e-05	0.000293	CcSEcCtD
Ganciclovir—Somnolence—Losartan—type 2 diabetes mellitus	9.97e-05	0.000293	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	9.96e-05	0.000293	CcSEcCtD
Ganciclovir—Asthenia—Valsartan—type 2 diabetes mellitus	9.95e-05	0.000292	CcSEcCtD
Ganciclovir—Discomfort—Ramipril—type 2 diabetes mellitus	9.91e-05	0.000291	CcSEcCtD
Ganciclovir—Dyspepsia—Losartan—type 2 diabetes mellitus	9.87e-05	0.00029	CcSEcCtD
Ganciclovir—Asthenia—Orlistat—type 2 diabetes mellitus	9.83e-05	0.000289	CcSEcCtD
Ganciclovir—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	9.82e-05	0.000289	CcSEcCtD
Ganciclovir—Pruritus—Valsartan—type 2 diabetes mellitus	9.81e-05	0.000288	CcSEcCtD
Ganciclovir—Dry mouth—Ramipril—type 2 diabetes mellitus	9.81e-05	0.000288	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	9.78e-05	0.00378	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	9.78e-05	0.00378	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	9.77e-05	0.00377	CbGpPWpGaD
Ganciclovir—Decreased appetite—Losartan—type 2 diabetes mellitus	9.75e-05	0.000287	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	9.74e-05	0.000286	CcSEcCtD
Ganciclovir—Confusional state—Ramipril—type 2 diabetes mellitus	9.7e-05	0.000285	CcSEcCtD
Ganciclovir—Pruritus—Orlistat—type 2 diabetes mellitus	9.69e-05	0.000285	CcSEcCtD
Ganciclovir—Fatigue—Losartan—type 2 diabetes mellitus	9.67e-05	0.000284	CcSEcCtD
Ganciclovir—Oedema—Ramipril—type 2 diabetes mellitus	9.62e-05	0.000283	CcSEcCtD
Ganciclovir—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	9.62e-05	0.000283	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	9.61e-05	0.00371	CbGpPWpGaD
Ganciclovir—Vomiting—Gliclazide—type 2 diabetes mellitus	9.6e-05	0.000282	CcSEcCtD
Ganciclovir—Pain—Losartan—type 2 diabetes mellitus	9.59e-05	0.000282	CcSEcCtD
Ganciclovir—Constipation—Losartan—type 2 diabetes mellitus	9.59e-05	0.000282	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	9.58e-05	0.0037	CbGpPWpGaD
Ganciclovir—Rash—Gliclazide—type 2 diabetes mellitus	9.52e-05	0.00028	CcSEcCtD
Ganciclovir—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.51e-05	0.000279	CcSEcCtD
Ganciclovir—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.49e-05	0.000279	CcSEcCtD
Ganciclovir—Urticaria—Irbesartan—type 2 diabetes mellitus	9.47e-05	0.000278	CcSEcCtD
Ganciclovir—Headache—Gliclazide—type 2 diabetes mellitus	9.45e-05	0.000278	CcSEcCtD
Ganciclovir—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.42e-05	0.000277	CcSEcCtD
Ganciclovir—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.42e-05	0.000277	CcSEcCtD
Ganciclovir—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	9.41e-05	0.000277	CcSEcCtD
Ganciclovir—Tachycardia—Ramipril—type 2 diabetes mellitus	9.38e-05	0.000276	CcSEcCtD
Ganciclovir—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.37e-05	0.000276	CcSEcCtD
Ganciclovir—Skin disorder—Ramipril—type 2 diabetes mellitus	9.34e-05	0.000275	CcSEcCtD
Ganciclovir—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9.3e-05	0.000273	CcSEcCtD
Ganciclovir—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.24e-05	0.000272	CcSEcCtD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	9.23e-05	0.00356	CbGpPWpGaD
Ganciclovir—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.17e-05	0.00027	CcSEcCtD
Ganciclovir—Dizziness—Valsartan—type 2 diabetes mellitus	9.17e-05	0.00027	CcSEcCtD
Ganciclovir—Anorexia—Ramipril—type 2 diabetes mellitus	9.17e-05	0.000269	CcSEcCtD
Ganciclovir—Dizziness—Orlistat—type 2 diabetes mellitus	9.06e-05	0.000266	CcSEcCtD
Ganciclovir—Asthenia—Metformin—type 2 diabetes mellitus	9.06e-05	0.000266	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	9.06e-05	0.0035	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—GAD2—type 2 diabetes mellitus	9.01e-05	0.00348	CbGpPWpGaD
Ganciclovir—Hypotension—Ramipril—type 2 diabetes mellitus	8.99e-05	0.000264	CcSEcCtD
Ganciclovir—Nausea—Gliclazide—type 2 diabetes mellitus	8.96e-05	0.000264	CcSEcCtD
Ganciclovir—Pruritus—Metformin—type 2 diabetes mellitus	8.93e-05	0.000263	CcSEcCtD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	8.92e-05	0.00344	CbGpPWpGaD
Ganciclovir—Urticaria—Losartan—type 2 diabetes mellitus	8.91e-05	0.000262	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	8.88e-05	0.00343	CbGpPWpGaD
Ganciclovir—Body temperature increased—Losartan—type 2 diabetes mellitus	8.87e-05	0.000261	CcSEcCtD
Ganciclovir—Abdominal pain—Losartan—type 2 diabetes mellitus	8.87e-05	0.000261	CcSEcCtD
Ganciclovir—Vomiting—Valsartan—type 2 diabetes mellitus	8.82e-05	0.000259	CcSEcCtD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	8.81e-05	0.0034	CbGpPWpGaD
Ganciclovir—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	8.78e-05	0.000258	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	8.76e-05	0.000258	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	8.75e-05	0.00338	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	8.75e-05	0.00338	CbGpPWpGaD
Ganciclovir—Rash—Valsartan—type 2 diabetes mellitus	8.74e-05	0.000257	CcSEcCtD
Ganciclovir—Dermatitis—Valsartan—type 2 diabetes mellitus	8.73e-05	0.000257	CcSEcCtD
Ganciclovir—Vomiting—Orlistat—type 2 diabetes mellitus	8.71e-05	0.000256	CcSEcCtD
Ganciclovir—Insomnia—Ramipril—type 2 diabetes mellitus	8.7e-05	0.000256	CcSEcCtD
Ganciclovir—Headache—Valsartan—type 2 diabetes mellitus	8.69e-05	0.000255	CcSEcCtD
Ganciclovir—Diarrhoea—Metformin—type 2 diabetes mellitus	8.64e-05	0.000254	CcSEcCtD
Ganciclovir—Rash—Orlistat—type 2 diabetes mellitus	8.64e-05	0.000254	CcSEcCtD
Ganciclovir—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.63e-05	0.000254	CcSEcCtD
Ganciclovir—Dermatitis—Orlistat—type 2 diabetes mellitus	8.63e-05	0.000254	CcSEcCtD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	8.62e-05	0.00333	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	8.6e-05	0.00332	CbGpPWpGaD
Ganciclovir—Headache—Orlistat—type 2 diabetes mellitus	8.58e-05	0.000252	CcSEcCtD
Ganciclovir—Dyspnoea—Ramipril—type 2 diabetes mellitus	8.57e-05	0.000252	CcSEcCtD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	8.56e-05	0.00331	CbGpPWpGaD
Ganciclovir—Asthenia—Irbesartan—type 2 diabetes mellitus	8.55e-05	0.000251	CcSEcCtD
Ganciclovir—Somnolence—Ramipril—type 2 diabetes mellitus	8.55e-05	0.000251	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	8.54e-05	0.0033	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	8.54e-05	0.0033	CbGpPWpGaD
Ganciclovir—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.46e-05	0.000249	CcSEcCtD
Ganciclovir—Pruritus—Irbesartan—type 2 diabetes mellitus	8.43e-05	0.000248	CcSEcCtD
Ganciclovir—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.36e-05	0.000246	CcSEcCtD
Ganciclovir—Dizziness—Metformin—type 2 diabetes mellitus	8.35e-05	0.000245	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	8.32e-05	0.00321	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	8.31e-05	0.00321	CbGpPWpGaD
Ganciclovir—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.3e-05	0.000244	CcSEcCtD
Ganciclovir—Fatigue—Ramipril—type 2 diabetes mellitus	8.29e-05	0.000244	CcSEcCtD
Ganciclovir—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.26e-05	0.000243	CcSEcCtD
Ganciclovir—Nausea—Valsartan—type 2 diabetes mellitus	8.24e-05	0.000242	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	8.22e-05	0.00317	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	8.22e-05	0.00317	CbGpPWpGaD
Ganciclovir—Constipation—Ramipril—type 2 diabetes mellitus	8.22e-05	0.000242	CcSEcCtD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	8.21e-05	0.00317	CbGpPWpGaD
Ganciclovir—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.15e-05	0.00024	CcSEcCtD
Ganciclovir—SLC22A1—Neuronal System—KCNJ11—type 2 diabetes mellitus	8.15e-05	0.00314	CbGpPWpGaD
Ganciclovir—Nausea—Orlistat—type 2 diabetes mellitus	8.14e-05	0.000239	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	8.08e-05	0.00312	CbGpPWpGaD
Ganciclovir—Asthenia—Losartan—type 2 diabetes mellitus	8.05e-05	0.000237	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	8.03e-05	0.0031	CbGpPWpGaD
Ganciclovir—Vomiting—Metformin—type 2 diabetes mellitus	8.03e-05	0.000236	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	8e-05	0.00309	CbGpPWpGaD
Ganciclovir—Rash—Metformin—type 2 diabetes mellitus	7.96e-05	0.000234	CcSEcCtD
Ganciclovir—Dermatitis—Metformin—type 2 diabetes mellitus	7.95e-05	0.000234	CcSEcCtD
Ganciclovir—Pruritus—Losartan—type 2 diabetes mellitus	7.93e-05	0.000233	CcSEcCtD
Ganciclovir—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.92e-05	0.000233	CcSEcCtD
Ganciclovir—Headache—Metformin—type 2 diabetes mellitus	7.91e-05	0.000233	CcSEcCtD
Ganciclovir—Dizziness—Irbesartan—type 2 diabetes mellitus	7.88e-05	0.000232	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.86e-05	0.000231	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	7.7e-05	0.00297	CbGpPWpGaD
Ganciclovir—Diarrhoea—Losartan—type 2 diabetes mellitus	7.67e-05	0.000226	CcSEcCtD
Ganciclovir—Urticaria—Ramipril—type 2 diabetes mellitus	7.64e-05	0.000225	CcSEcCtD
Ganciclovir—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.6e-05	0.000223	CcSEcCtD
Ganciclovir—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.6e-05	0.000223	CcSEcCtD
Ganciclovir—Vomiting—Irbesartan—type 2 diabetes mellitus	7.58e-05	0.000223	CcSEcCtD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	7.58e-05	0.00292	CbGpPWpGaD
Ganciclovir—Rash—Irbesartan—type 2 diabetes mellitus	7.51e-05	0.000221	CcSEcCtD
Ganciclovir—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.51e-05	0.000221	CcSEcCtD
Ganciclovir—Nausea—Metformin—type 2 diabetes mellitus	7.5e-05	0.00022	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	7.47e-05	0.00288	CbGpPWpGaD
Ganciclovir—Headache—Irbesartan—type 2 diabetes mellitus	7.47e-05	0.000219	CcSEcCtD
Ganciclovir—Dizziness—Losartan—type 2 diabetes mellitus	7.42e-05	0.000218	CcSEcCtD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	7.17e-05	0.00277	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	7.15e-05	0.00276	CbGpPWpGaD
Ganciclovir—Vomiting—Losartan—type 2 diabetes mellitus	7.13e-05	0.00021	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	7.13e-05	0.00275	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	7.13e-05	0.00275	CbGpPWpGaD
Ganciclovir—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.08e-05	0.000208	CcSEcCtD
Ganciclovir—Nausea—Irbesartan—type 2 diabetes mellitus	7.08e-05	0.000208	CcSEcCtD
Ganciclovir—Rash—Losartan—type 2 diabetes mellitus	7.07e-05	0.000208	CcSEcCtD
Ganciclovir—Dermatitis—Losartan—type 2 diabetes mellitus	7.06e-05	0.000208	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	7.04e-05	0.00272	CbGpPWpGaD
Ganciclovir—Headache—Losartan—type 2 diabetes mellitus	7.03e-05	0.000207	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	6.99e-05	0.0027	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	6.98e-05	0.00269	CbGpPWpGaD
Ganciclovir—Asthenia—Ramipril—type 2 diabetes mellitus	6.9e-05	0.000203	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	6.86e-05	0.00265	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	6.86e-05	0.00265	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	6.85e-05	0.00264	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	6.85e-05	0.00264	CbGpPWpGaD
Ganciclovir—Pruritus—Ramipril—type 2 diabetes mellitus	6.8e-05	0.0002	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	6.8e-05	0.00262	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	6.8e-05	0.00262	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	6.75e-05	0.00261	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	6.74e-05	0.0026	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	6.69e-05	0.00258	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	6.68e-05	0.00258	CbGpPWpGaD
Ganciclovir—Nausea—Losartan—type 2 diabetes mellitus	6.66e-05	0.000196	CcSEcCtD
Ganciclovir—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.58e-05	0.000193	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	6.47e-05	0.0025	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	6.38e-05	0.00246	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	6.38e-05	0.00246	CbGpPWpGaD
Ganciclovir—Dizziness—Ramipril—type 2 diabetes mellitus	6.36e-05	0.000187	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	6.23e-05	0.00241	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	6.23e-05	0.0024	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	6.22e-05	0.0024	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	6.19e-05	0.00239	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	6.16e-05	0.00238	CbGpPWpGaD
Ganciclovir—Vomiting—Ramipril—type 2 diabetes mellitus	6.11e-05	0.00018	CcSEcCtD
Ganciclovir—Rash—Ramipril—type 2 diabetes mellitus	6.06e-05	0.000178	CcSEcCtD
Ganciclovir—Dermatitis—Ramipril—type 2 diabetes mellitus	6.06e-05	0.000178	CcSEcCtD
Ganciclovir—Headache—Ramipril—type 2 diabetes mellitus	6.02e-05	0.000177	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	5.84e-05	0.00225	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	5.83e-05	0.00225	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—SNAP25—type 2 diabetes mellitus	5.8e-05	0.00224	CbGpPWpGaD
Ganciclovir—Nausea—Ramipril—type 2 diabetes mellitus	5.71e-05	0.000168	CcSEcCtD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	5.66e-05	0.00218	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	5.64e-05	0.00218	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	5.62e-05	0.00217	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	5.55e-05	0.00214	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	5.54e-05	0.00214	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	5.54e-05	0.00214	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	5.43e-05	0.00209	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	5.4e-05	0.00209	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	5.36e-05	0.00207	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	5.36e-05	0.00207	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	5.33e-05	0.00206	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	5.33e-05	0.00206	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	5.32e-05	0.00206	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	5.24e-05	0.00202	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	5.24e-05	0.00202	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	5.21e-05	0.00201	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	5.18e-05	0.002	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	5.18e-05	0.002	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	5.05e-05	0.00195	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	5.03e-05	0.00194	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	4.96e-05	0.00192	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	4.84e-05	0.00187	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	4.69e-05	0.00181	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	4.56e-05	0.00176	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	4.53e-05	0.00175	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	4.53e-05	0.00175	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—BHMT—type 2 diabetes mellitus	4.52e-05	0.00174	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	4.48e-05	0.00173	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	4.48e-05	0.00173	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	4.38e-05	0.00169	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	4.37e-05	0.00169	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	4.35e-05	0.00168	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	4.34e-05	0.00168	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—GNB3—type 2 diabetes mellitus	4.34e-05	0.00167	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	4.34e-05	0.00167	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	4.32e-05	0.00167	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	4.28e-05	0.00165	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	4.26e-05	0.00164	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	4.23e-05	0.00163	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	4.22e-05	0.00163	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	4.2e-05	0.00162	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	4.17e-05	0.00161	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	4.08e-05	0.00157	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	4.07e-05	0.00157	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PTGDS—type 2 diabetes mellitus	3.95e-05	0.00152	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—AANAT—type 2 diabetes mellitus	3.95e-05	0.00152	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—ADCY5—type 2 diabetes mellitus	3.87e-05	0.00149	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.81e-05	0.00147	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	3.81e-05	0.00147	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GPD2—type 2 diabetes mellitus	3.74e-05	0.00144	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CDO1—type 2 diabetes mellitus	3.74e-05	0.00144	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	3.64e-05	0.00141	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	3.63e-05	0.0014	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.6e-05	0.00139	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.58e-05	0.00138	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—AK1—type 2 diabetes mellitus	3.57e-05	0.00138	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.55e-05	0.00137	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	3.53e-05	0.00136	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.48e-05	0.00134	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	3.48e-05	0.00134	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	3.48e-05	0.00134	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.44e-05	0.00133	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.43e-05	0.00132	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	3.4e-05	0.00131	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	3.38e-05	0.0013	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	3.36e-05	0.0013	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—CALM1—type 2 diabetes mellitus	3.32e-05	0.00128	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SLC5A4—type 2 diabetes mellitus	3.3e-05	0.00127	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—MAT1A—type 2 diabetes mellitus	3.3e-05	0.00127	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.23e-05	0.00125	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.2e-05	0.00124	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—HBA2—type 2 diabetes mellitus	3.18e-05	0.00123	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—G6PC—type 2 diabetes mellitus	3.18e-05	0.00123	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ND1—type 2 diabetes mellitus	3.18e-05	0.00123	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ENPP1—type 2 diabetes mellitus	3.18e-05	0.00123	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PPP1R3C—type 2 diabetes mellitus	3.18e-05	0.00123	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—PRKCB—type 2 diabetes mellitus	3.12e-05	0.0012	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GCGR—type 2 diabetes mellitus	3.08e-05	0.00119	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3e-05	0.00116	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.99e-05	0.00115	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.96e-05	0.00114	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	2.96e-05	0.00114	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—OXCT1—type 2 diabetes mellitus	2.91e-05	0.00112	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYTB—type 2 diabetes mellitus	2.91e-05	0.00112	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.89e-05	0.00112	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.86e-05	0.0011	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SRD5A1—type 2 diabetes mellitus	2.84e-05	0.0011	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	2.82e-05	0.00109	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	2.74e-05	0.00106	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.71e-05	0.00105	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—STAR—type 2 diabetes mellitus	2.71e-05	0.00104	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ACACA—type 2 diabetes mellitus	2.71e-05	0.00104	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—HSD17B3—type 2 diabetes mellitus	2.71e-05	0.00104	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	2.71e-05	0.00104	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.67e-05	0.00103	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ABCC8—type 2 diabetes mellitus	2.59e-05	0.001	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CBS—type 2 diabetes mellitus	2.59e-05	0.001	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.56e-05	0.000987	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—COX2—type 2 diabetes mellitus	2.5e-05	0.000964	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SLC5A2—type 2 diabetes mellitus	2.5e-05	0.000964	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—NCOA6—type 2 diabetes mellitus	2.45e-05	0.000947	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.41e-05	0.000932	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—UCP2—type 2 diabetes mellitus	2.41e-05	0.000931	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—HSD11B1—type 2 diabetes mellitus	2.41e-05	0.000931	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—UCP3—type 2 diabetes mellitus	2.41e-05	0.000931	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.33e-05	0.0009	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.32e-05	0.000896	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.3e-05	0.000888	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PCK1—type 2 diabetes mellitus	2.27e-05	0.000875	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.26e-05	0.000874	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.22e-05	0.000858	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.15e-05	0.00083	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—HK1—type 2 diabetes mellitus	2.12e-05	0.00082	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.08e-05	0.000802	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GCKR—type 2 diabetes mellitus	2.05e-05	0.000792	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—KCNJ11—type 2 diabetes mellitus	2.05e-05	0.000792	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—LPA—type 2 diabetes mellitus	2.05e-05	0.000792	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—HSD3B2—type 2 diabetes mellitus	2.05e-05	0.000792	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ALDOB—type 2 diabetes mellitus	1.97e-05	0.000759	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.88e-05	0.000724	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GLP1R—type 2 diabetes mellitus	1.83e-05	0.000706	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.79e-05	0.000692	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.76e-05	0.000679	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.71e-05	0.000659	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—MTR—type 2 diabetes mellitus	1.67e-05	0.000645	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CPT1A—type 2 diabetes mellitus	1.67e-05	0.000645	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—NAMPT—type 2 diabetes mellitus	1.64e-05	0.000633	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GCK—type 2 diabetes mellitus	1.63e-05	0.000629	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—LIPC—type 2 diabetes mellitus	1.63e-05	0.000629	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—HBA1—type 2 diabetes mellitus	1.63e-05	0.000629	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.62e-05	0.000625	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.59e-05	0.000614	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CETP—type 2 diabetes mellitus	1.57e-05	0.000607	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SNAP25—type 2 diabetes mellitus	1.46e-05	0.000564	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SREBF1—type 2 diabetes mellitus	1.46e-05	0.000564	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PSMD6—type 2 diabetes mellitus	1.46e-05	0.000564	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CTGF—type 2 diabetes mellitus	1.43e-05	0.000554	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—HMGCR—type 2 diabetes mellitus	1.42e-05	0.000549	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.39e-05	0.000538	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.39e-05	0.000537	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.34e-05	0.000516	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.32e-05	0.00051	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.32e-05	0.00051	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.29e-05	0.000498	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GCG—type 2 diabetes mellitus	1.27e-05	0.000489	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.27e-05	0.000489	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GNB3—type 2 diabetes mellitus	1.09e-05	0.000422	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.09e-05	0.000422	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—HMOX1—type 2 diabetes mellitus	1.09e-05	0.00042	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CAT—type 2 diabetes mellitus	1.07e-05	0.000414	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—APOB—type 2 diabetes mellitus	1.04e-05	0.000402	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GSTM1—type 2 diabetes mellitus	1.01e-05	0.000391	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—LPL—type 2 diabetes mellitus	9.94e-06	0.000384	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ADCY5—type 2 diabetes mellitus	9.74e-06	0.000376	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GPX1—type 2 diabetes mellitus	9.7e-06	0.000374	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CD36—type 2 diabetes mellitus	9.45e-06	0.000365	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PPP2CA—type 2 diabetes mellitus	9.33e-06	0.00036	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—MTHFR—type 2 diabetes mellitus	8.95e-06	0.000346	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PPARA—type 2 diabetes mellitus	8.78e-06	0.000339	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—AGT—type 2 diabetes mellitus	8.51e-06	0.000328	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CALM1—type 2 diabetes mellitus	8.36e-06	0.000323	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—APOE—type 2 diabetes mellitus	8.34e-06	0.000322	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—APOA1—type 2 diabetes mellitus	8.24e-06	0.000318	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PPARG—type 2 diabetes mellitus	7.26e-06	0.00028	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—INS—type 2 diabetes mellitus	7.12e-06	0.000275	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ALB—type 2 diabetes mellitus	6.53e-06	0.000252	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—NOS3—type 2 diabetes mellitus	6.24e-06	0.000241	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PIK3R1—type 2 diabetes mellitus	6.24e-06	0.000241	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	5.71e-06	0.00022	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	2.87e-06	0.000111	CbGpPWpGaD
